Dynavax Technologies Corporation (LON:0IDA)
15.39
+4.28 (38.56%)
At close: Dec 24, 2025
Dynavax Technologies Revenue
Dynavax Technologies had revenue of $94.88M USD in the quarter ending September 30, 2025, with 17.67% growth. This brings the company's revenue in the last twelve months to $330.51M, up 26.73% year-over-year. In the year 2024, Dynavax Technologies had annual revenue of $277.25M with 19.36% growth.
Revenue (ttm)
$330.51M
Revenue Growth
+26.73%
P/S Ratio
5.45
Revenue / Employee
$816.08K
Employees
405
Market Cap
1.34B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 277.25M | 44.96M | 19.36% |
| Dec 31, 2023 | 232.28M | -490.40M | -67.86% |
| Dec 31, 2022 | 722.68M | 283.24M | 64.45% |
| Dec 31, 2021 | 439.44M | 392.89M | 844.00% |
| Dec 31, 2020 | 46.55M | 11.33M | 32.18% |
| Dec 31, 2019 | 35.22M | 27.02M | 329.60% |
| Dec 31, 2018 | 8.20M | 7.87M | 2,407.03% |
| Dec 31, 2017 | 327.00K | -10.72M | -97.04% |
| Dec 31, 2016 | 11.04M | 6.99M | 172.67% |
| Dec 31, 2015 | 4.05M | -6.98M | -63.29% |
| Dec 31, 2014 | 11.03M | -219.00K | -1.95% |
| Dec 31, 2013 | 11.25M | 1.54M | 15.82% |
| Dec 31, 2012 | 9.71M | -11.90M | -55.06% |
| Dec 31, 2011 | 21.61M | -2.34M | -9.75% |
| Dec 31, 2010 | 23.95M | -16.37M | -40.60% |
| Dec 31, 2009 | 40.32M | 3.22M | 8.69% |
| Dec 31, 2008 | 37.09M | 23.00M | 163.21% |
| Dec 31, 2007 | 14.09M | 9.25M | 190.76% |
| Dec 31, 2006 | 4.85M | -9.81M | -66.93% |
| Dec 31, 2005 | 14.66M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| Convatec Group | 1.72B |
| Genus | 672.80M |
| HUTCHMED (China) | 439.54M |
Dynavax Technologies News
- 24 days ago - Dynavax Technologies Corp at Evercore ISI Healthcare Conference Transcript - GuruFocus
- 26 days ago - DVAX Crosses Below Key Moving Average Level - Nasdaq
- 4 weeks ago - First Week of July 2026 Options Trading For Dynavax Technologies (DVAX) - Nasdaq
- 5 weeks ago - Dynavax to Participate at the 8th Annual Evercore Healthcare Conference - PRNewsWire
- 6 weeks ago - Vaxart (VXRT) Secures $700 Million Partnership with Dynavax - GuruFocus
- 6 weeks ago - Vaxart extends cash runway into Q2 2027 with Dynavax partnership and targets 2026 data readouts - Seeking Alpha
- 7 weeks ago - Decoding Dynavax Technologies Corp (DVAX): A Strategic SWOT Insight - GuruFocus
- 7 weeks ago - Dynavax Technologies Corp (DVAX) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... - GuruFocus